Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios.
about
Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteersCentral nervous system effects of the second-generation antihistamines marketed in Japan--review of inter-drug differences using the proportional impairment ratio (PIR)-Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study.Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.Fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders.Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations.Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteersManagement of seasonal allergic rhinitis: comparative efficacy of the newer-generation prescription antihistamines.Pediatric allergic rhinitis: antihistamine selection.Treatment for allergic rhinitis and chronic idiopathic urticaria: focus on oral antihistamines.Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination: a new treatment option for allergic rhinitis.H1 antihistamines: current status and future directions.Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.Positron emission tomography evaluation of sedative properties of antihistamines.Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving.H1-antihistamines Reduce Progression to Anaphylaxis Among Emergency Department Patients With Allergic Reactions.Assessment of the first and second generation antihistamines brain penetration and role of P-glycoprotein.Histamine H1-receptor blockade in humans affects psychomotor performance but not memory.Low doses of mirtazapine or quetiapine for transient insomnia: A randomised, double-blind, cross-over, placebo-controlled trial.Psychomotor and subjective effects of bilastine, hydroxyzine, and cetirizine, in combination with alcohol: a randomized, double-blind, crossover, and positive-controlled and placebo-controlled Phase I clinical trials.Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine.The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions.
P2860
Q24563637-BDA4984B-B404-49CC-B83F-4605DC6FB1ACQ28542698-03545B5B-23A5-4994-AA0C-9DB14201195FQ30475256-D8A2C7B8-72A0-4608-AF3E-946D1A7B8841Q34337549-D20516A1-AB65-4F52-B493-7419755014CFQ34988193-913D1C36-0E64-413E-A594-76338885A584Q35212261-259F6203-25D5-4D61-8377-7D900E237546Q35904482-01847FFF-964B-44D2-B229-944F4052924AQ36207884-339D766A-A0E6-4E7D-A103-B09721F15D45Q36279844-1FBDA02B-9932-42C5-B7A8-32AA8BE466F9Q36309636-3384304F-77F1-4B81-9EBE-34C684FD5046Q36458473-F86E9A4A-56AE-43F0-840E-0023D9246B4CQ36834344-D562A6AA-632F-4202-BAF2-0C166BE8B3E9Q36834774-E5E49F24-722A-4119-BD90-4D87E2FE9133Q37355700-B5FEE1F2-B954-4811-9662-4E334EF56F15Q37869149-BF6F9C26-C52B-4316-86FD-1DB1F0C51022Q38634137-E71747CC-00AD-40EA-952B-BD9B634B5815Q39099562-D91A1769-65A9-4333-9860-13FC48525BDEQ40192152-E1583F34-C4F9-4B69-B1B0-011C7093632BQ46798714-69CAA2F2-F90D-4E60-8053-F6E73706117EQ47774281-EDE581E1-C398-4EFE-8779-BD6B882989E7Q47933632-78E3C656-C379-46D2-9F16-AD6E76263B21Q48010806-6A252130-5827-4489-9606-5679F6C745CDQ50919551-D7394D22-93DD-4810-AFAD-0E444191C4BB
P2860
Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Sedation and antihistamines: a ...... roportional impairment ratios.
@ast
Sedation and antihistamines: a ...... roportional impairment ratios.
@en
Sedation and antihistamines: a ...... roportional impairment ratios.
@nl
type
label
Sedation and antihistamines: a ...... roportional impairment ratios.
@ast
Sedation and antihistamines: a ...... roportional impairment ratios.
@en
Sedation and antihistamines: a ...... roportional impairment ratios.
@nl
prefLabel
Sedation and antihistamines: a ...... roportional impairment ratios.
@ast
Sedation and antihistamines: a ...... roportional impairment ratios.
@en
Sedation and antihistamines: a ...... roportional impairment ratios.
@nl
P2860
P1476
Sedation and antihistamines: a ...... roportional impairment ratios.
@en
P2093
P2860
P304
P356
10.1002/1099-1077(200010)15:1+<::AID-HUP247>3.0.CO;2-S
P577
2000-10-01T00:00:00Z